mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.4 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.4 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.4 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.4 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.4 |